These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6233785)

  • 1. Mode of interference of trisodium phosphonoformate (INN: foscarnet sodium), with influenza virus mRNA synthesis.
    Stridh S; Datema R
    Virology; 1984 May; 135(1):293-6. PubMed ID: 6233785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of foscarnet and foscarnet esters as anti-influenza virus agents.
    Strid S; Ekström C; Datema R
    Chemotherapy; 1989; 35(1):69-76. PubMed ID: 2524368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1982; 19(3):387-415. PubMed ID: 6201932
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxicity of intravitreal injection of foscarnet in the rabbit eye.
    She SC; Peyman GA; Schulman JA
    Int Ophthalmol; 1988; 12(2):151-4. PubMed ID: 2976408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1989; 40(2):213-85. PubMed ID: 2543994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration-dependent effects of foscarnet on the cell cycle.
    Stenberg K; Skog S; Tribukait B
    Antimicrob Agents Chemother; 1985 Dec; 28(6):802-6. PubMed ID: 2935075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of vesicular stomatitis virus transcriptase in vitro by phosphonoformate and ara-ATP.
    Chanda PK; Banerjee AK
    Virology; 1980 Dec; 107(2):562-6. PubMed ID: 6161479
    [No Abstract]   [Full Text] [Related]  

  • 8. Trisodium phosphonoformate, a new antiviral compound.
    Helgstrand E; Eriksson B; Johansson NG; Lannerö B; Larsson A; Misiorny A; Norén JO; Sjöberg B; Stenberg K; Stening G; Stridh S; Oberg B
    Science; 1978 Sep; 201(4358):819-21. PubMed ID: 210500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet.
    Koshida R; Vrang L; Gilljam G; Harmenberg J; Oberg B; Wahren B
    Antimicrob Agents Chemother; 1989 May; 33(5):778-80. PubMed ID: 2526616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of foscarnet on herpesvirus multiplication in cell culture.
    Schnürer J; Oberg B
    Arch Virol; 1981; 68(3-4):203-9. PubMed ID: 6268019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No in vivo effect of trisodium phosphonoformate on woodchuck hepatitis virus production.
    Nordenfelt E; Widell A; Hansson BG; Löfgren B; Möller-Nielsen C; Oberg B
    Acta Pathol Microbiol Immunol Scand B; 1982 Dec; 90(6):449-51. PubMed ID: 6220563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate.
    Margalith M; Falk H; Panet A
    Mol Cell Biochem; 1982 Mar; 43(2):97-103. PubMed ID: 6178013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks.
    Sherker AH; Hirota K; Omata M; Okuda K
    Gastroenterology; 1986 Oct; 91(4):818-24. PubMed ID: 2943628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiviral activity of phosphonoacetic acid, phosphonopropionic acid, and trisodium phosphonoformate hexahydrate against herpesvirus hominis type 1 and type 2 in vitro].
    Thiel KD; Wutzler P; Sprössig M; Bertram D
    Pharmazie; 1982 Aug; 37(8):608. PubMed ID: 6292963
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of action of foscarnet against viral polymerases.
    Crumpacker CS
    Am J Med; 1992 Feb; 92(2A):3S-7S. PubMed ID: 1371038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of action of phosphonoformate as an anti-herpes simplex virus agent.
    Cheng YC; Grill S; Derse D; Chen JY; Caradonna SJ; Connor K
    Biochim Biophys Acta; 1981 Jan; 652(1):90-8. PubMed ID: 6260189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trisodium phosphonoformate inhibits woodchuck hepatitis virus associated DNA polymerase.
    Nordenfelt E; Werner B
    Acta Pathol Microbiol Scand B; 1980 Jun; 88(3):183-4. PubMed ID: 6449828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphonoformate inhibits reverse transcriptase.
    Sundquist B; Oberg B
    J Gen Virol; 1979 Nov; 45(2):273-81. PubMed ID: 94344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus hepatitis in mice: effects of treatment with trisodium phosphonoformate.
    Ulbricht A; Färber I; Wutzler P
    Acta Virol; 1985 Dec; 29(6):493-8. PubMed ID: 2869661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hepatitis-B-virus DNA polymerase by phosphonoformate: studies on its mode of action.
    Hess G; Arnold W; Meyer zum Büschenfelde KH
    J Med Virol; 1980; 5(4):309-16. PubMed ID: 6453206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.